[Novel therapeutic approaches to diabetic nephropathy].
Miyata
Toshio
T
D000818:Animals; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000209:etiology; D015195:Drug Design; D015894:Genome, Human; D023281:Genomics; D006801:Humans; D051793:Hypoxia-Inducible Factor 1 / Q000502:physiology; D017395:Plasminogen Activator Inhibitor 1 / Q000502:physiology; D015843:Serpins / Q000235:genetics / Q000276:immunology / Q000502:physiology
D051793:Hypoxia-Inducible Factor 1; D017395:Plasminogen Activator Inhibitor 1; C114170:SERPINB7 protein, human; D015843:Serpins